Healthcare

The impact investor’s recently launched inclusive growth strategy focuses on businesses that are delivering positive outcomes for vulnerable people in the UK.

Ultromics raised the financing in a Series C funding round, led by Lightrock, L&G, and Allegis Capital, for the expansion of its AI-powered diagnostic echocardiogram technology, which was developed in partnership with the UK NHS and Mayo Clinic.

The African healthcare firm has grown into a chain serving two million customers a year. LeapFrog has sold its remaining stake to CFAO Healthcare.

The €260m impact investment fund has invested into Happyneuron, a company specialised in cognitive health assessment and rehabilitation.

Serah Melaba, chief impact officer for Tiko, discusses tackling the triple threat of teen pregnancy, HIV and sexual and gender-based violence facing girls in sub-Saharan Africa, and how impact-linked financing is driving positive outcomes.

The Belgian biotech firm has developed an antibody against gastrointestinal infections in pigs that can reduce the reliance on antibiotics in animal production.

Barcelona-based Aortyx has developed a life-saving vascular patch that can mend torn aortas, and plans to test the new devices in a clinical trial with humans within two years.  

The company is developing commercial-scale regenerative cell therapy for a range of illnesses, with Parkinson’s disease a priority area of research.

The fund aims to help UK-based health tech startups to scale up domestically and internationally with support from leading healthcare institutions.

The pension fund said the partnership builds on its existing collaboration with Achmea IM and represented a step towards greater sustainability of its investments.